|
US4311688A
(en)
*
|
1979-10-29 |
1982-01-19 |
Serono Laboratories Inc. |
Composition and method for cancer detection in humans
|
|
US4472371A
(en)
*
|
1979-10-29 |
1984-09-18 |
Summa Medical Corporation |
Radiolabeled antibody to anti-tumor associated antigen and process
|
|
USRE32417E
(en)
*
|
1979-10-29 |
1987-05-12 |
Summa Medical Corporation |
Radiolabeled antibody to anti-tumor associated antigen and process
|
|
US4855126A
(en)
*
|
1980-07-10 |
1989-08-08 |
Chembiomed Ltd. |
Method to detect T-antigen delayed hypersensitivity
|
|
EP0090025A4
(en)
*
|
1981-09-28 |
1984-01-12 |
Roberto Luis Ceriani |
IDENTIFICATION OF A SPECIFIC CHEST Gland.
|
|
US4584268A
(en)
*
|
1981-10-13 |
1986-04-22 |
Ceriani Roberto Luis |
Method and compositions for carcinoma diagnosis
|
|
NL8204108A
(nl)
*
|
1981-10-27 |
1983-05-16 |
Hybritech Inc |
In beeld brengen van tumor met radioactief gemerkte monoclonale antilichamen.
|
|
GB2122641B
(en)
*
|
1982-06-07 |
1986-08-06 |
Otto A Gansow |
Metal chelate conjugated monoclonal antibodies where in the metal is an emitter
|
|
US4454106A
(en)
*
|
1982-06-07 |
1984-06-12 |
Gansow Otto A |
Use of metal chelate conjugated monoclonal antibodies
|
|
US4472509A
(en)
*
|
1982-06-07 |
1984-09-18 |
Gansow Otto A |
Metal chelate conjugated monoclonal antibodies
|
|
US4624846A
(en)
*
|
1983-07-29 |
1986-11-25 |
Immunomedics, Inc. |
Method for enhancing target specificity of antibody localization and clearance of non-target diagnostic and therapeutic principles
|
|
ATE61000T1
(de)
*
|
1983-07-29 |
1991-03-15 |
Milton David Goldenberg |
Verfahren zur erhoehung der zielspezifizitaet in antikoerperbestimmungen und zur raeumung von nichtzielspezifischen diagnostischen und therapeutischen faktoren.
|
|
US4782840A
(en)
*
|
1984-03-02 |
1988-11-08 |
Neoprobe Corporation |
Method for locating, differentiating, and removing neoplasms
|
|
US4652440A
(en)
*
|
1984-05-03 |
1987-03-24 |
Paik Chang H |
Method of stably radiolabeling antibodies with technetium and rhenium
|
|
US4665897A
(en)
*
|
1984-05-25 |
1987-05-19 |
Lemelson Jerome H |
Composition and method for detecting and treating cancer
|
|
US4674480A
(en)
*
|
1984-05-25 |
1987-06-23 |
Lemelson Jerome H |
Drug compositions and methods of applying same
|
|
JPS6117065A
(ja)
*
|
1984-07-04 |
1986-01-25 |
Mitsui Toatsu Chem Inc |
ヒト絨毛性ゴナドトロピンの測定試薬
|
|
US4692332A
(en)
*
|
1985-01-18 |
1987-09-08 |
Mcmichael John |
Immunotherapeutic methods and compositions employing antigens characteristic of malignant neoplasms
|
|
US4689222A
(en)
*
|
1985-01-18 |
1987-08-25 |
Mcmichael John |
Methods and materials for alleviation of pain symptoms of malignant neoplasia
|
|
US4880626A
(en)
*
|
1985-01-18 |
1989-11-14 |
Mcmichael John |
Immunotherapeutic methods and compositions for the treatment of diseases of viral origin, including acquired immune deficiency syndrome
|
|
US4826672A
(en)
*
|
1985-06-07 |
1989-05-02 |
President And Fellows Of Harvard College |
Astatinated organic compounds
|
|
US4830847A
(en)
*
|
1985-06-28 |
1989-05-16 |
The Procter & Gamble Company |
Diphosphonate-derivatized macromolecules
|
|
US4735210A
(en)
*
|
1985-07-05 |
1988-04-05 |
Immunomedics, Inc. |
Lymphographic and organ imaging method and kit
|
|
US5776093A
(en)
*
|
1985-07-05 |
1998-07-07 |
Immunomedics, Inc. |
Method for imaging and treating organs and tissues
|
|
GB8519457D0
(en)
*
|
1985-08-02 |
1985-09-11 |
Faulk Ward Page |
Tumour imaging agents
|
|
WO1987004164A1
(en)
*
|
1986-01-06 |
1987-07-16 |
The University Of Melbourne |
Technetium-antibody conjugate
|
|
US4877868A
(en)
*
|
1986-03-12 |
1989-10-31 |
Neorx Corporation |
Radionuclide antibody coupling
|
|
US5320941A
(en)
*
|
1986-06-06 |
1994-06-14 |
Dallan Young |
DNA sequence encoding mas onhcogene, polypeptides encoded therefrom and diagnostic and other methods based therefrom
|
|
US4863713A
(en)
*
|
1986-06-23 |
1989-09-05 |
The Board Of Trustees Of Leland Stanford Jr. Univ. |
Method and system for administering therapeutic and diagnostic agents
|
|
US4762701A
(en)
*
|
1986-10-31 |
1988-08-09 |
Smithkline Beckman Corporation |
In vivo cellular tracking
|
|
US4877599A
(en)
*
|
1986-11-10 |
1989-10-31 |
New England Deaconess Hospital Corporation |
Detection of vascular disease with labelled antibodies
|
|
DE3728599A1
(de)
*
|
1986-12-10 |
1988-06-23 |
Hoechst Ag |
Verfahren zur herstellung einer mit technetium-99m-markierten organspezifischen substanz
|
|
US5053493A
(en)
*
|
1987-04-02 |
1991-10-01 |
Centocor Cardiovascular Imaging Partners, L.P. |
Method for labeling antibodies with a metal ion
|
|
US5648471A
(en)
*
|
1987-12-03 |
1997-07-15 |
Centocor, Inc. |
One vial method for labeling antibodies with Technetium-99m
|
|
US5084266A
(en)
*
|
1988-02-03 |
1992-01-28 |
The University Of Melbourne |
Method for tumor imaging utilizing a labelled tumor specific antibody and a non-tumor reactive antibody
|
|
US4867962A
(en)
*
|
1988-02-26 |
1989-09-19 |
Neorx Corporation |
Functionally specific antibodies
|
|
US5128119A
(en)
*
|
1989-06-12 |
1992-07-07 |
Immunomedics, Inc. |
Methods for technetium/rhenium labeling of f(ab1)2 fragments
|
|
US5179008A
(en)
*
|
1989-02-09 |
1993-01-12 |
Wisconsin Alumni Research Foundation |
Hybridoma and monoclonal antibody to FHAP
|
|
US5001052A
(en)
*
|
1989-02-09 |
1991-03-19 |
Wisconsin Alumni Research Foundation |
Immunoassay for FHAP and antibody useful therewith
|
|
US5279968A
(en)
*
|
1989-07-20 |
1994-01-18 |
Syncor International Corporation |
Method of labelling leucocytes with Tc-99m, d,1-HMPAO
|
|
US5346687A
(en)
*
|
1989-08-09 |
1994-09-13 |
Rhomed Incorporated |
Direct radiolabeling of antibody against stage specific embryonic antigen for diagnostic imaging
|
|
US5460785A
(en)
*
|
1989-08-09 |
1995-10-24 |
Rhomed Incorporated |
Direct labeling of antibodies and other protein with metal ions
|
|
US5102990A
(en)
*
|
1989-08-09 |
1992-04-07 |
Rhomed Incorporated |
Direct radiolabeling of antibodies and other proteins with technetium or rhenium
|
|
US5078985A
(en)
*
|
1989-08-09 |
1992-01-07 |
Rhomed, Incorporated |
Radiolabeling antibodies and other proteins with technetium or rhenium by regulated reduction
|
|
CA1340250C
(en)
*
|
1989-09-18 |
1998-12-15 |
Hans J. Hansen |
Method for rapidly radiolabeling monovalent antibody fragments with technetium
|
|
US5130129A
(en)
*
|
1990-03-06 |
1992-07-14 |
The Regents Of The University Of California |
Method for enhancing antibody transport through capillary barriers
|
|
US5011676A
(en)
*
|
1990-03-27 |
1991-04-30 |
Thomas Jefferson University |
Method to directly radiolabel antibodies for diagnostic imaging and therapy
|
|
FI920459A
(fi)
*
|
1991-02-05 |
1992-08-06 |
Hoechst Ag |
Foerfarande foer framstaellning av ett med teknetium-99m maerkt organspecifikt aemne.
|
|
JPH07506830A
(ja)
*
|
1992-05-15 |
1995-07-27 |
マリンクロット・メディカル・インコーポレイテッド |
炎症検出用診断剤の製造法
|
|
EP0654973A4
(en)
*
|
1992-07-21 |
1995-08-09 |
Gen Hospital Corp |
LYPHATIC TISSUE DRUG ADMINISTRATION SYSTEM.
|
|
US5756825A
(en)
*
|
1992-09-08 |
1998-05-26 |
Safavy; Ahmad |
Hydroxamic acid-based bifunctional chelating compounds
|
|
US5670132A
(en)
*
|
1994-09-20 |
1997-09-23 |
Immunomedics, Inc. |
Modified radioantibody fragments for reduced renal uptake
|
|
US5900377A
(en)
*
|
1997-03-03 |
1999-05-04 |
Syncor International Corporation |
Method for isolating and radiolabeling leukocytes for use in vivo
|
|
US6080384A
(en)
*
|
1997-03-25 |
2000-06-27 |
American Biogenetic Sciences, Inc. |
Methods for radionuclide-labeling of biomolecules and kits utilizing the same
|
|
US7666609B1
(en)
*
|
1998-12-01 |
2010-02-23 |
Shanghai Cp Guojian Pharmaceutical Co. Ltd. |
Method and composition for diagnosis of melanocytic lesions
|
|
US20020117169A1
(en)
|
2001-02-27 |
2002-08-29 |
Kurz Daniel R. |
Cover and applicator for a portion of a mammalian body
|
|
ATE353954T1
(de)
*
|
2002-10-11 |
2007-03-15 |
Sentoclone Therapeutics Ab |
Immuntherapie für krebs
|
|
EP1554584B1
(en)
*
|
2002-10-11 |
2008-05-07 |
Sentina Biotechnology Incorporated |
Methods for detection of breast cancer
|
|
CN1279056C
(zh)
*
|
2003-06-06 |
2006-10-11 |
马菁 |
肿瘤相关抗原sm5－1的特异性抗体及其应用
|
|
US20050232926A1
(en)
*
|
2003-06-06 |
2005-10-20 |
Oncomax Acquisition Corp. |
Antibodies specific for cancer associated antigen SM5-1 and uses thereof
|
|
AU2004303448A1
(en)
|
2003-12-23 |
2005-07-07 |
Mount Sinai Hospital |
Methods for detecting markers associated with endometrial disease or phase
|
|
JP5205275B2
(ja)
*
|
2005-12-21 |
2013-06-05 |
セントクローネ インターナショナル エービー |
散在性ガンの治療法
|
|
AU2006328943B2
(en)
*
|
2005-12-21 |
2011-07-21 |
Sentoclone International Ab |
Improved method for expansion of tumour-reactive T-lymphocytes for immunotherapy of patients with cancer
|
|
WO2007071390A1
(en)
*
|
2005-12-21 |
2007-06-28 |
Sentoclone Ab |
Method for treating malignant melanoma
|
|
US8101173B2
(en)
*
|
2005-12-21 |
2012-01-24 |
Sentoclone International Ab |
Method for treating urinary bladder cancer
|
|
WO2008049239A1
(en)
|
2006-10-27 |
2008-05-02 |
Mount Sinai Hospital |
Endometrial biomarkers
|
|
US20100256464A1
(en)
*
|
2007-05-14 |
2010-10-07 |
Dr. Susan Love Research Foundation |
Device for determining risk of developing breast cancer and method thereof
|
|
CA2618163A1
(en)
|
2008-02-07 |
2009-08-07 |
K. W. Michael Siu |
Head and neck cancer biomarkers
|
|
WO2010006808A1
(en)
*
|
2008-07-18 |
2010-01-21 |
Sentoclone Ab |
Composition comprising in vitro expanded t-lymphocytes and vessel formation inhibitors suitable in the treatment of cancer
|
|
EP2606165B1
(en)
|
2010-08-16 |
2016-10-12 |
Sinai Health System |
Markers of the male urogenital tract
|
|
US8668900B2
(en)
|
2011-02-15 |
2014-03-11 |
Kuwait University |
Cancer-imaging agent and method of radioimaging using the same
|
|
EP3559037A1
(en)
|
2016-12-22 |
2019-10-30 |
Wake Forest University Health Sciences |
Sirp-gamma targeted agents for use in the treatment of cancer
|
|
EP4200613A1
(en)
|
2020-08-19 |
2023-06-28 |
Theraonco |
Monosaccharide compound for the labelling of cell secretion
|